Concepedia

Effects of AGI-1067 and Probucol After Percutaneous Coronary Interventions

Jean‐Claude Tardif, Jean Grégoire, Leonard Schwartz, Lawrence Title, Louise Laramée, François Reeves, Jacques Lespérance, Martial G. Bourassa, Philippe L. L’Allier, Mitchell Glass,

Circulation · 2003 · 179 citations · 18 references

DOIFull text

Open access

Abstract

AGI-1067 and probucol reduce restenosis after PCI. In contrast to probucol, AGI-1067 did not cause prolongation of the QTc interval and improved lumen dimensions of reference segments, suggestive of a direct effect on atherosclerosis.

References

18

The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion

Todd J. Anderson, Ian T. Meredith, Alan C. Yeung et al. · New England Journal of Medicine · 1995 · 1.1K citations

Probucol and Multivitamins in the Prevention of Restenosis after Coronary Angioplasty

Jean‐Claude Tardif, Gilles Côté, Jacques Lespérance et al. · New England Journal of Medicine · 1997 · 567 citations

Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant

Vincent W. Bowry, K. U. Ingold, Roland Stocker · Biochemical Journal · 1992 · 509 citations

, , +18

Gene Transfer and Hepatic Overexpression of the HDL Receptor SR-BI Reduces Atherosclerosis in the Cholesterol-Fed LDL Receptor–Deficient Mouse

Karen Kozarsky, Mary H. Donahee, Jane M. Glick et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 335 citations · Full text

Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia

Yasunori Sawayama, Chie Shimizu, Naoyasu Maeda et al. · Journal of the American College of Cardiology · 2002 · 224 citations

, , +10